Hyperoside ameliorates diabetic nephropathy induced by STZ via targeting the miR-499-5p/APC axis

• Main Authors: Jingbo Zhou (Author), Shu Zhang (Author), Xinyi Sun (Author), Yan Lou (Author), Jinjing Bao (Author), Jiangyi Yu (Author)
• Format: Book
• Published: Elsevier, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Diabetic nephropathy is a serious complication of diabetes. Hyperoside has been widely reported to ameliorate diabetes-associated disease. The current study is designed to explore the mechanism of hyperoside in diabetic nephropathy. In the present study, high glucose was used to treat podocytes. Dia...